Literature DB >> 8062246

Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.

G M Hampton1, A Mannermaa, R Winqvist, M Alavaikko, G Blanco, P J Taskinen, H Kiviniemi, I Newsham, W K Cavenee, G A Evans, R Winquist.   

Abstract

The development of sporadic human breast cancer is associated with the accumulation of genetic alterations on several chromosomes. In the case of chromosome 11, loss of heterozygosity (LOH) at loci on the short arm has been well documented and suggests the presence of a suppressor gene(s) at 11p15.5. However, the evidence for similar events on the long arm is less compelling. Here, we determined the prevalence of LOH for chromosome 11q in 44 malignant and 3 benign cases of unselected sporadic breast tumor samples. We found that alteration of chromosome 11q is common in the pathogenesis of breast cancer as 19 of 44 (43%) malignant tumor specimens exhibited LOH. Eleven (58%) of these genetic alterations were specific to the long arm of the chromosome. The smallest region of shared LOH places the target between 11q22 and 11q23.3, the same general region frequently altered in cancers of the ovary, colon, skin, and uterine cervix, perhaps indicating the location of a tumor suppressor gene or genes of importance in each of these different tumor types.

Entities:  

Mesh:

Year:  1994        PMID: 8062246

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Tightly clustered 11q23 and 22q11 breakpoints permit PCR-based detection of the recurrent constitutional t(11;22).

Authors:  H Kurahashi; T H Shaikh; E H Zackai; L Celle; D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  2000-07-20       Impact factor: 11.025

2.  ei24, a p53 response gene involved in growth suppression and apoptosis.

Authors:  Z Gu; C Flemington; T Chittenden; G P Zambetti
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  The long and short of chromosome 11 in breast cancer.

Authors:  I F Newsham
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

4.  TRIM29 suppresses TWIST1 and invasive breast cancer behavior.

Authors:  Lingbao Ai; Wan-Ju Kim; Merve Alpay; Ming Tang; Carolina E Pardo; Shigetsugu Hatakeyama; W Stratford May; Michael P Kladde; Coy D Heldermon; Erin M Siegel; Kevin D Brown
Journal:  Cancer Res       Date:  2014-06-20       Impact factor: 12.701

5.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

6.  Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.

Authors:  Anjali Teckchandani; George S Laszlo; Sergi Simó; Khyati Shah; Carissa Pilling; Alexander A Strait; Jonathan A Cooper
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

7.  Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide.

Authors:  Christina N Mork; Douglas V Faller; Remco A Spanjaard
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

8.  Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene.

Authors:  D DiSepio; C Ghosn; R L Eckert; A Deucher; N Robinson; M Duvic; R A Chandraratna; S Nagpal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Authors:  Eric S Martin; Rossano Cesari; Francesca Pentimalli; Kristine Yoder; Richard Fishel; Andrew L Himelstein; S Eric Martin; Andrew K Godwin; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

10.  The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma.

Authors:  Dong-Ja Kim; Ji-Young Park; Myung-Hoon Lee; Yoon-Kyung Sohn
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.